We. Vannostrand et al., AMYLOID BETA-PROTEIN PRECURSOR IN CULTURED LEPTOMENINGEAL SMOOTH-MUSCLE CELLS, AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1(1), 1994, pp. 1-7
Smooth muscle cell cultures were established from human leptomeningeal
blood vessels obtained at autopsy from a patient with normal cortical
blood vessels and a patient with extensive cerebral amyloid angiopath
y (CAA). The normal leptomeningeal smooth muscle cells and CAA/ leptom
eningeal smooth muscle cells were compared to normal human aorta smoot
h muscle cells with respect to amyloid beta-protein precursor (A beta
PP) expression. All the cultured smooth muscle cells secreted a promin
ent approximate to 110 kDa form of A beta PP that contained the Kunitz
-type serine protease inhibitor domain analogous to protease nexin-2 (
PN-2). Quantitative measurements revealed that aorta smooth muscle cel
ls secrete approximate to 1.5-fold more PN-2/ABPP than normal leptomen
ingeal smooth muscle cells and CAA/ leptomeningeal smooth muscle cells
. In contrast the normal leptomeningeal smooth muscle cells and CAA/ l
eptomeningeal smooth muscle cells retain approximate to 2.4- and appro
ximate to 3.3-fold, respectively, more cell-associated A beta PP than
aorta smooth muscle cells. These preliminary findings suggest that the
decreased secretion of PN-2/A beta PP observed in leptomeningeal smoo
th muscle cells compared to aorta smooth muscle cells may contribute t
o the formation of AP that is selectively deposited in the waifs of co
rtical and leptomeningeal blood vessels.